Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
CVKD
$0.94
-0.47%
CVKD
· Cadrenal Therapeutics, Inc.
$0.94
0.00 (-0.47%)
At close · Oct 29
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.38M
Shares
3.57M
Volume · Oct 29
44.03K
Avg daily vol (3M)
461.96K
All webcasts
Earnings call · FY2023 Q4
Cadrenal Therapeutics, Inc. (CVKD) Q4 2023 Earnings Call
Net income · derived Q4
-$1.14M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 11, 2024 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 11, 2024 · complete as-filed document